insights_auto
Why is ALDX up 3.33%?
Dive Deeperchevron_right
ALDX:NASDAQ
Aldeyra Therapeutics Inc
$1.40
arrow_upward
+3.33%(+0.045) 1D
$1.39
arrow_downward
-0.29% (-0.0040)bedtimeAfter hours
Closed: Sep 22, 4:00:01 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALDX...
Open
$1.37
High
$1.40
Low
$1.35
Mkt. cap
84.16M
Avg. vol.
707.22K
Volume
0.00
52-wk high
$5.93
52-wk low
$1.07
EPS
-$0.38
Beta
1.20
Shares outstanding
60.33M
No. of employees
6
Open
$1.37
High
$1.40
Low
$1.35
Mkt. cap
84.16M
Avg. vol.
707.22K
Volume
0.00
52-wk high
$5.93
52-wk low
$1.07
EPS
-$0.38
Beta
1.20
Shares outstanding
60.33M
No. of employees
6
News stories
From web sources and news partners
Zacks
·
13 hours ago
AbbVie's Rinvoq Wins EU Approval in Juvenile Idiopathic Arthritis
Zacks
·
15 hours ago
Novo's CagriSema Outshines Zepbound in Key Phase III Weight-Loss Study
About Aldeyra Therapeutics Inc
CEOTodd C. Brady M.D., Ph.D.
Employees6
Founded2004
HeadquartersLexington, Massachusetts, United States
SectorBiotechnology
Websitealdeyra.com